{
    "2021-04-26": [
        [
            {
                "time": "",
                "original_text": "【权益变动】泰格医药(03347-HK)被FMRLLC减持38.79万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "减持",
                        "FMRLLC",
                        "38.79万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-26",
                "original_text": "泰格医药4月26日大宗交易成交827.09万元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "827.09万元"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药今日大宗交易成交5.42万股，成交价152.6元溢价0.0%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "5.42万股",
                        "152.6元",
                        "溢价0.0%"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "CRO板块集体下挫，科创板美迪西跌超10%",
                "features": {
                    "keywords": [
                        "CRO板块",
                        "下挫",
                        "美迪西",
                        "跌超10%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "八大券商主题策略：深度挖掘疫苗产业链机会 核心资产标的名单曝光",
                "features": {
                    "keywords": [
                        "券商",
                        "主题策略",
                        "疫苗产业链",
                        "核心资产"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)获贝莱德增持11.91万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "贝莱德",
                        "增持",
                        "11.91万股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}